RxSight, Inc. - Common Stock, par value $0.001 per share (RXST) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
RXST on Nasdaq
Shares outstanding
40,783,326
Price per share
$10.42
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
33,240,985
Total reported value
$298,840,768
% of total 13F portfolios
0%
Share change
-5,003,516
Value change
-$91,248,116
Number of holders
156
Price from insider filings
$10.42
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RxSight, Inc. - Common Stock, par value $0.001 per share (RXST) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 5.8% $21,515,668 2,393,289 BlackRock, Inc. 30 Sep 2025
MILLENNIUM MANAGEMENT LLC 5.4% -17% $19,715,627 -$3,757,056 2,193,062 -16% Millennium Management LLC 30 Sep 2025
Artisan Partners Limited Partnership 4.3% -24% $15,765,610 -$4,484,760 1,753,683 -22% Artisan Partners Asset Management Inc. 30 Sep 2025
Divisadero Street Capital Management, LP 0.5% -97% $2,003,100 -$21,160,317 218,918 -91% Divisadero Street Capital Management, LP 30 Jun 2025
BANK OF AMERICA CORP /DE/ 0.4% -100% $1,574,633 -$18,388,728 172,091 -92% BANK OF AMERICA CORP /DE/ 30 Jun 2025
LORD, ABBETT & CO. LLC 0% $24,336 1,715 Lord, Abbett & Co. LLC 31 Dec 2024

As of 30 Sep 2025, 156 institutional investors reported holding 33,240,985 shares of RxSight, Inc. - Common Stock, par value $0.001 per share (RXST). This represents 82% of the company’s total 40,783,326 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of RxSight, Inc. - Common Stock, par value $0.001 per share (RXST) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 6.6% 2,702,682 -10% 0% $24,297,110
MILLENNIUM MANAGEMENT LLC 5.4% 2,193,062 +131% 0.02% $19,715,627
VANGUARD GROUP INC 5.3% 2,147,059 -5.8% 0% $19,302,061
D. E. Shaw & Co., Inc. 4.5% 1,833,891 +39% 0.01% $16,486,680
Artisan Partners Limited Partnership 4.3% 1,753,683 -22% 0.02% $15,765,610
No Street GP LP 4% 1,625,000 +35% 0.97% $14,608,750
CITADEL ADVISORS LLC 3.2% 1,290,144 +26% 0.01% $11,598,394
DEUTSCHE BANK AG\ 2.4% 967,616 -21% 0% $8,698,868
BNP PARIBAS FINANCIAL MARKETS 2.2% 903,846 0% 0.01% $8,125,576
MORGAN STANLEY 2.1% 844,653 -16% 0% $7,593,433
STATE STREET CORP 2% 824,144 -10% 0% $7,409,055
BROWN CAPITAL MANAGEMENT LLC 1.9% 771,180 -31% 0.29% $6,932,908
GEODE CAPITAL MANAGEMENT, LLC 1.8% 739,301 -14% 0% $6,647,843
UBS Group AG 1.8% 735,170 +183% 0% $6,609,178
TWO SIGMA ADVISERS, LP 1.8% 730,200 +303% 0.01% $6,564,498
BANK OF AMERICA CORP /DE/ 1.8% 722,435 +406% 0% $6,494,690
BAILLIE GIFFORD & CO 1.7% 686,316 +46% 0% $6,169,981
TWO SIGMA INVESTMENTS, LP 1.6% 662,417 +50% 0.01% $5,955,129
Schonfeld Strategic Advisors LLC 1.4% 557,601 +110% 0.04% $5,012,830
4D Advisors, LLC 1.4% 554,930 +344% 2.7% $4,988,821
ROYAL BANK OF CANADA 1.2% 494,408 -6.6% 0% $4,447,000
Grandeur Peak Global Advisors, LLC 1% 420,690 +117% 0.51% $3,782,003
Parkman Healthcare Partners LLC 0.93% 380,713 -40% 0.38% $3,422,610
GOLDMAN SACHS GROUP INC 0.92% 373,547 +48% 0% $3,358,187
Atika Capital Management LLC 0.87% 354,907 0% 0.27% $3,190,613

Institutional Holders of RxSight, Inc. - Common Stock, par value $0.001 per share (RXST) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 121,734 $1,268,328 -$246,509 $10.42 12
2025 Q3 33,240,985 $298,840,768 -$91,248,116 $8.99 156
2025 Q2 37,016,695 $481,217,558 -$21,810,787 $13.00 171
2025 Q1 36,568,753 $923,318,226 +$17,779,769 $25.25 191
2024 Q4 35,313,536 $1,213,991,115 -$14,840,880 $34.38 210
2024 Q3 33,943,055 $1,677,693,596 +$13,787,501 $49.43 215
2024 Q2 32,938,720 $1,981,762,396 +$144,428,630 $60.17 226
2024 Q1 30,605,744 $1,578,621,673 +$69,912,365 $51.58 196
2023 Q4 69,246 $2,791,999 +$1,370,034 $40.32 2
2023 Q3 25,420,184 $708,972,244 +$96,602,537 $27.89 125
2023 Q2 21,931,786 $631,659,097 +$194,526,129 $28.80 114
2023 Q1 15,284,879 $254,962,674 +$100,354,098 $16.68 71
2022 Q4 9,610,667 $121,610,751 +$6,374,499 $12.67 55
2022 Q3 9,110,247 $109,310,492 -$3,348,885 $12.00 52
2022 Q2 9,305,838 $131,026,291 +$7,945,794 $14.08 47
2022 Q1 8,749,769 $108,303,000 +$25,971,386 $12.38 43
2021 Q4 6,663,380 $74,962,000 -$15,725,830 $11.25 39
2021 Q3 7,920,040 $100,348,000 +$100,347,912 $12.67 39